New WHO programme members

WHO programme / 15 April 2020

Photo: iStock

The WHO Programme for International Drug Monitoring continues to grow. Since we last reported on programme membership (Issue 81, October 2019), three countries have become full members: Luxembourg (January 2020), Saint Vincent and the Grenadines (March), and Nicaragua (April). In addition, Belize and Dominican Republic joined as associate members (January and March, respectively).

The programme now stands at 139 full and 32 associate members.

 

Read more:

Related Articles

WHO programme member update – March 2021

UMC director Marie Lindquist to retire – Board appoints Hervé Le Louët as new CEO

National centres share experience at 42nd annual meeting

You may also like

National centres share experience at 42nd annual meeting

The 42nd Annual NC meeting drew the global pharmacovigilance community to Bogotá, Colombia for an intensive programme of learning, experience sharing and inspiration.

WHO programme / 11 March 2020

WHO programme member update – March 2021

Recent additions mean the WHO Programme for International Drug Monitoring now stands at 143 full members and 28 associate members.

WHO programme / 30 March 2021

UMC director Marie Lindquist to retire – Board appoints Hervé Le Louët as new CEO

UMC today announced the forthcoming retirement of its longstanding director, Marie Lindquist, and the appointment of Hervé Le Louët as the organisation’s new CEO.

WHO programme / 21 August 2020

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more